Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus (ORDI-02)

This study has been completed.
Information provided by:
Hospital Universitari Vall d'Hebron Research Institute Identifier:
First received: July 19, 2011
Last updated: August 2, 2011
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):